文献速递真菌感染

不依赖培养的分子方法检测抗真菌耐药机制与真菌鉴定

Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.
PubMed 文献 · J Infect Dis · 2017-01-01

侵袭性真菌感染中唑类和棘白菌素类耐药影响临床管理,免疫抑制患者因长期或反复暴露于抗真菌药物而面临耐药风险。核酸分子诊断可快速检测低丰度真菌、鉴定菌种并评估耐药机制,基于实时PCR的等位特异性检测技术有望更快识别耐药株并指导治疗。

要点

  • 免疫抑制患者长期或反复使用抗真菌药可筛选天然低敏感菌种或诱导原位耐药机制。
  • 核酸分子诊断适于快速检测低丰度真菌、鉴定至属种水平并评估耐药机制。
  • 实时PCR等位特异性检测可快速识别耐药株,为治疗管理提供依据。

核心结论

  • 不依赖培养的分子方法可快速检测真菌并鉴定至属种水平,同时评估耐药机制,有望改善侵袭性真菌感染患者的临床管理。

研究设计与样本

  • 本文为综述,汇总了核酸分子诊断技术(包括实时PCR和等位特异性检测)在真菌鉴定和抗真菌耐药机制检测中的应用。

主要发现

  • 免疫抑制患者长期或反复暴露于抗真菌药可导致天然低敏感真菌菌种的选择或特定耐药机制的原位发展。
  • 实时PCR技术可直接分析无菌血液标本中的单个感染基因组,已有商业化产品(如Roche LightCycler SeptiFast和T2 Biosystems T2Candida)。
  • 检测经独立验证导致耐药的机制可作为不依赖培养的生物标志物,提示潜在治疗失败。

关键数值与推荐

  • 实时PCR等位特异性分子检测技术具有高灵敏度、稳健性和高通量特点,可快速检测耐药感染株。

临床怎么用

  • 临床可利用不依赖培养的分子方法快速鉴定真菌至属种水平并检测耐药机制,以指导抗真菌治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Resistance to azoles and echinocandins has emerged as a significant factor affecting the clinical management of patients with invasive fungal infections. Immunosuppressed patients at high risk for invasive fungal infections often have prolonged or repeated exposure to antifungals resulting in either the well-documented selection of naturally occurring, less susceptible fungal species, or the in situ development of specific resistance mechanisms. Nucleic acid-based molecular diagnostics are particularly well suited for the rapid detection of low-abundance fungal pathogens and identification of the infecting pathogen to the genus and species levels, as well as assessment of resistance mechanisms. A wide range of molecular probing technologies involving real-time polymerase chain reaction (PCR) assays that facilitate direct analysis of a single infecting genome in a sterile blood specimen are available and have recently been commercialized (eg, Roche LightCycler SeptiFast and T2 Biosystems T2Candida). One of the exciting applications of molecular technology is the direct detection of specific resistance mechanisms that evolve during therapy. In principle, the detection of resistance mechanisms that have been independently validated to cause resistance provides a culture-independent biomarker for potential therapeutic failure. The emergence of real-time PCR assays utilizing allele-specific molecular detection technology that is highly sensitive, robust, and high-throughput has the potential to improve patient care by providing faster detection of drug-resistant infecting strains and to help inform therapeutic management.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Perlin DS, Wiederhold NP. Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification. J Infect Dis. 2017. PMID: 28911041. doi:10.1093/infdis/jix121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。